as of 03-11-2026 12:27pm EST
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
| Founded: | 2008 | Country: | Israel |
| Employees: | N/A | City: | N/A |
| Market Cap: | 842.0M | IPO Year: | 2018 |
| Target Price: | $16.75 | AVG Volume (30 days): | 870.5K |
| Analyst Decision: | Hold | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $12.95 - $19.09 | Next Earning Date: | N/A |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | 1.7% | Revenue Growth (next year): | 3.99% |
| P/E Ratio: | 10.11 | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | -36.15% |
See how INMD stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "INMD InMode Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.